Received May 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
2 additional individuals contracting the Hantavirus due to the adverse effect of the Pfizer vaccine named Pfizer-BioNTech; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HANTAVIRAL INFECTION (medically significant), outcome "unknown", described as "2 additional individuals contracting the Hantavirus due to the adverse effect of the Pfizer vaccine named Pfizer-BioNTech". Additional information: 2 additional individuals contracting the Hantavirus due to the adverse effect of the Pfizer vaccine named Pfizer-BioNTech. The reporter mention that the most recent occurrence is "since 08Feb2021". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202600048785 same reporter/product, different patient;US-PFIZER INC-PV202600048787 same reporter/product, different patient;